Cargando…
Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
Immunosuppressant drugs (ISDs) are routinely used in clinical practice to maintain organ transplant survival. However, these drugs are characterized by a restricted therapeutic index, a high inter- and intra-individual pharmacokinetic variability, and a series of severe adverse effects. In particula...
Autores principales: | Urzì Brancati, Valentina, Scarpignato, Carmelo, Minutoli, Letteria, Pallio, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332547/ https://www.ncbi.nlm.nih.gov/pubmed/35892699 http://dx.doi.org/10.3390/biomedicines10081798 |
Ejemplares similares
-
Polymorphisms Affecting the Response to Novel Antiepileptic Drugs
por: Urzì Brancati, Valentina, et al.
Publicado: (2023) -
Identification and Targeting of Mutant Neoantigens in Multiple Myeloma Treatment
por: Brancati, Valentina Urzì, et al.
Publicado: (2023) -
Combined Treatment with Polynucleotides and Hyaluronic Acid Improves Tissue Repair in Experimental Colitis
por: Pallio, Giovanni, et al.
Publicado: (2020) -
Individualized immunosuppression in transplant patients: potential role of pharmacogenetics
por: Abboudi, Hamid, et al.
Publicado: (2012) -
Nutraceuticals as Alternative Approach against Cadmium-Induced Kidney Damage: A Narrative Review
por: Marini, Herbert Ryan, et al.
Publicado: (2023)